Clinical Trial Update: Comparison of Bio-Active-Stent to the Everolimus-Eluting Stent in Acute Coronary Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is comparing a Bio-Active-Stent with an Everolimus-Eluting Stent in patients with Acute Coronary Syndrome; the trial status is listed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Bio-Active-stent
• Everolimus-eluting stent (everolimus-eluting stent)

Snippet

Sponsor: The Hospital District of Satakunta | Conditions: Acute Coronary Syndrome | Phase 3 | Status: UNKNOWN